Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lena F Burbulla

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Trends in Neurosciences|February 4, 2026
Mitochondrial specialization and signaling shape neuronal functionBenjamin Chun-Kit Tong, Francesco Gubinelli, Lena F Burbulla, et al.
Science Translational Medicine|October 18, 2019
A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's diseaseLena F Burbulla, Sohee Jeon, Jianbin Zheng, et al.
ACS Biomaterials Science & Engineering|October 23, 2020
Gelator length precisely tunes supramolecular hydrogel stiffness and neuronal phenotype in 3D cultureJacqueline M Godbe, Ronit Freeman, Lena F Burbulla, et al.
Cells|December 24, 2021
Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic NeuronsLeonie M Heger, Rachel M Wise, J Tabitha Hees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2021
Modeling Brain Pathology of Niemann-Pick Disease Type C Using Patient-Derived NeuronsLena F Burbulla, Jessica M Mc Donald, Clarissa Valdez, et al.
JCI Insight|October 8, 2021
Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson's disease modelsLena F Burbulla, Jianbin Zheng, Pingping Song, et al.
Journal of Medicinal Chemistry|January 16, 2019
Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJianbin Zheng, Sohee Jeon, Weilan Jiang, et al.
Scientific Reports|June 15, 2026
Aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microgliaGamze Özata, Rachel M Wise, Aida Cardona-Alberich, et al.
Neurobiology of Disease|November 9, 2022
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disordersRachel M Wise, Annika Wagener, Urban M Fietzek, et al.
Journal of Clinical Medicine|January 1, 2020
Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson's Disease PatientsClara Berenguer-Escuder, Dajana Grossmann, Franҫois Massart, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Trends in Neurosciences|February 4, 2026
Mitochondrial specialization and signaling shape neuronal functionBenjamin Chun-Kit Tong, Francesco Gubinelli, Lena F Burbulla, et al.
Science Translational Medicine|October 18, 2019
A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's diseaseLena F Burbulla, Sohee Jeon, Jianbin Zheng, et al.
ACS Biomaterials Science & Engineering|October 23, 2020
Gelator length precisely tunes supramolecular hydrogel stiffness and neuronal phenotype in 3D cultureJacqueline M Godbe, Ronit Freeman, Lena F Burbulla, et al.
Cells|December 24, 2021
Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic NeuronsLeonie M Heger, Rachel M Wise, J Tabitha Hees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2021
Modeling Brain Pathology of Niemann-Pick Disease Type C Using Patient-Derived NeuronsLena F Burbulla, Jessica M Mc Donald, Clarissa Valdez, et al.
JCI Insight|October 8, 2021
Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson's disease modelsLena F Burbulla, Jianbin Zheng, Pingping Song, et al.
Journal of Medicinal Chemistry|January 16, 2019
Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJianbin Zheng, Sohee Jeon, Weilan Jiang, et al.
Scientific Reports|June 15, 2026
Aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microgliaGamze Özata, Rachel M Wise, Aida Cardona-Alberich, et al.
Neurobiology of Disease|November 9, 2022
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disordersRachel M Wise, Annika Wagener, Urban M Fietzek, et al.
Journal of Clinical Medicine|January 1, 2020
Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson's Disease PatientsClara Berenguer-Escuder, Dajana Grossmann, Franҫois Massart, et al.
Pageof 5